LT-630

• Description:

  LT-630 is a HDAC6 inhibitor. LT-630 ameliorates liver injury by reducing oxidative damage[1].

• UNSPSC:

  12352005

• Target:

  HDAC

• Type:

  Reference compound

• Related Pathways:

  Cell Cycle/DNA Damage; Epigenetics

• Applications:

  COVID-19-anti-virus

• Field of Research:

  Inflammation/Immunology

• Assay Protocol:

  https://www.medchemexpress.com/lt-630.html

• Solubility:

  10 mM in DMSO

• Smiles:

  O=C (NO) C1=CC=C (CN2N=C (C (NC3=CC (F) =CC=C3) =O) C=C2C) C=C1

• Molecular Formula:

  C19H17FN4O3

• Molecular Weight:

  368.36

• References & Citations:

  [1]Zhang GD, et al. A novel HDAC6 inhibitor attenuate APAP-induced liver injury by regulating MDH1-mediated oxidative stress. Int Immunopharmacol. 2024 Mar 13;131:111861.

• Shipping Conditions:

  Room temperature

• Scientific Category:

  Reference compound1

• Clinical Information:

  No Development Reported

• Isoform:

  HDAC6